New Paradigms for Treatment of Locally Advanced NSCLC

New Paradigms for Treatment of Locally Advanced NSCLC

Episodes

Specialty:

All

Year:

All

EP. 1: New Paradigms for Treatment of Locally Advanced NSCLC

March 13th 2018

EP. 2: Locally Advanced NSCLC: Treatment Goals and Challenges

March 13th 2018

EP. 3: Key Considerations in the Management of Stage 3 NSCLC

March 13th 2018

EP. 4: Locally Advanced NSCLC: Treatment Overview

March 13th 2018

EP. 5: PACIFIC Trial: A Game Changer in Unresectable LA NSCLC

March 13th 2018

EP. 6: Chemotherapy Choices in the PACIFIC Trial

March 13th 2018

EP. 7: NSCLC: Consolidation Immunotherapy in Practice

March 13th 2018

EP. 8: Tips for Managing NSCLC Patients on Durvalumab Therapy

March 13th 2018

EP. 9: Improving Care in Locally Advanced NSCLC

March 13th 2018

EP. 10: Promising Developments in Locally Advanced NSCLC

March 13th 2018

EP. 11: Locally Advanced NSCLC: Audience Q&A

March 13th 2018

Trending on OncLive

INBRX-106 Plus Pembrolizumab Improves Responses and PFS in First-Line PD-L1–Positive HNSCC

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

The OncFive: Top Oncology Articles for the Week of 9/27/2026

NDA Submission Is Initiated for Zipalertinib Plus Chemotherapy in Frontline EGFR Exon 20 Insertion+ NSCLC

Five Under 5: Top Oncology Videos for the Week of 9/27